Xeris Biopharma Holdings, Inc.
← Back to XERS Overview

Xeris Biopharma Holdings, Inc. (XERS)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

29.39

Financial Fundamentals

XERSQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2017-03-31-2.20
2017-06-30-1.95
2017-09-30-1.36
2017-12-31-1.14
2018-03-31-0.92
2018-06-30-1.55
2018-09-30-2.39
2018-12-31-4.32
2019-03-31-2.26
2019-06-30-2.27
2019-09-30-2.02
2019-12-31-1.44
2020-03-31-0.55
2020-06-30-1.05
2020-09-30-4.28
2020-12-31-3.01
2021-03-31-3.75
2021-06-30-2.45
2021-09-30-1.57
2021-12-31-1.76
2022-03-31-2.56
2022-06-30-1.99
2022-09-30-2.43
2022-12-31-3.50
2023-03-31-3.32
2023-06-30-4.53
2023-09-30-5.27
2023-12-31-6.06
2024-03-31-3.96
2024-06-30-5.36
2024-09-30-6.75
2024-12-31-24.71
2025-03-31-22.69
2025-06-30-94.45
2025-09-30582.05
2025-12-3129.39

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.